Read Natalies Story Who Can Benefit Individuals who are overweight or obese and have struggled to lose weight through diet and exercise Patients with pre-diabetes, insulin resistance or type 2 diabetes Those experiencing weight-related conditions, such as high blood pressure, elevated cholesterol, fatty liver disease, cardiovascular disease and sleep apnea Individuals seeking a physician-guided, holistic weight-loss plan GLP-1 therapy may not be suitable for everyone, including individuals with certain thyroid, pancreatic or gastrointestinal conditions
Additionally, it aids in maintaining overall mineral balance and supports metabolic processes
TB, tuberculosis
It is a strategy some providers explore to potentially reduce side effects and allow for a more gradual adaptation to the medication
Tolerability, safety and pharmacodynamics of oral, small-molecule glucagon-like peptide-1 receptor agonist danuglipron for type 2 diabetes: a 12-week, randomized, placebo-controlled, phase 2 study comparing different dose-escalation schemes
doi: 10.1038/ejcn.2017.132